StockGlow

Navamedic ASA (NAVA.OL)

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.

16.40-0.03%Healthcare
Compare NAVA.OL with
StockGlow Score
21
Leaning Bearish
BearishBullish
1 year ago-30.2%

The outlook

Navamedic ASA currently reads as leaning bearish based on below its 50- & 200-day averages, 6% of the way from its 52-week low to high, avg target +43% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range6% of the way from its 52-week low to high
Price targetAvg target +43% vs current price

Analyst price target

~12-month · 2 analysts
23.50average target+43.3% vs now
Now 16.40
Low 21.00High 26.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$393.3M
52-wk high
27.90
52-wk low
15.70
50-day avg
16.77
200-day avg
20.23
Trailing P/E
—

Similar stocks

PHO.OLPhotocure ASA$54.30+1.88%MEDI.OLMedistim ASA$227.00+0.44%KIT.OLKitron ASA$88.10+1.79%GOD.OLGoodtech ASA$14.30-0.35%POL.OLPolaris Media ASA$57.40-0.69%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy